Literature DB >> 26388533

A worldwide shift in polio vaccines for routine immunisation.

Julie R Garon1, Walter A Orenstein2.   

Abstract

Mesh:

Substances:

Year:  2015        PMID: 26388533     DOI: 10.1016/S0140-6736(15)00243-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

1.  Immunogenicity and safety evaluation of bivalent types 1 and 3 oral poliovirus vaccine by comparing different poliomyelitis vaccination schedules in China: A randomized controlled non-inferiority clinical trial.

Authors:  Jingjun Qiu; Yunkai Yang; Lirong Huang; Ling Wang; Zhiwei Jiang; Jian Gong; Wei Wang; Hongyan Wang; Shaohong Guo; Chanjuan Li; Shuyuan Wei; Zhaojun Mo; Jielai Xia
Journal:  Hum Vaccin Immunother       Date:  2017-03-01       Impact factor: 3.452

2.  Thin silk fibroin films as a dried format for temperature stabilization of inactivated polio vaccine.

Authors:  Jordan A Stinson; Carter R Palmer; David P Miller; Adrian B Li; Kandice Lightner; Heather Jost; William C Weldon; M Steven Oberste; Jonathan A Kluge; Kathryn M Kosuda
Journal:  Vaccine       Date:  2020-01-17       Impact factor: 3.641

3.  Co-circulation of coxsackieviruses A-6, A-10, and A-16 causes hand, foot, and mouth disease in Guangzhou city, China.

Authors:  Jia Xie; Xiao-Han Yang; Si-Qi Hu; Wen-Li Zhan; Chang-Bin Zhang; Hong Liu; Hong-Yu Zhao; Hui-Ying Chai; Ke-Yi Chen; Qian-Yi Du; Pan Liu; Ai-Hua Yin; Ming-Yong Luo
Journal:  BMC Infect Dis       Date:  2020-04-07       Impact factor: 3.090

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.